Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.

Cancer genomics & proteomics - 1 Jan 2000

Weilandt Merlin, Koch Annemarie, Rieder Harald, Deenen René, Schwender Holger, Niegisch Günter, Schulz Wolfgang A

Abstract excerpt

BACKGROUND: Urothelial carcinoma (UC) is characterized by multiple recurrent chromosomal changes on a background of increasing genomic instability. To define target genes of recurrent deletions and amplifications, we explored which gene alterations are common in UC, in two recently established cell lines, BC44 and BC61. MATERIALS AND METHODS: Genes located in regions of gain or deletion in the cell lines were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Comparative Genomic Hybridization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Datasets as Topic

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Genomics

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 24969694

Genes

CCND1
CCNE1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.PMID 24969694Read ↗

Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.Semantic proximity Read ↗

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary TractSemantic proximity Read ↗

The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studiesSemantic proximity Read ↗

Identification of Common Differentially Expressed Genes in Urinary Bladder CancerSemantic proximity Read ↗

Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis.Semantic proximity Read ↗

Mapping of the chromosomal amplification 1p21-22 in bladder cancerSemantic proximity Read ↗

Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.Semantic proximity Read ↗

Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset.Semantic proximity Read ↗

Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinomaSemantic proximity Read ↗

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinomaSemantic proximity Read ↗

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.Semantic proximity Read ↗

Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.